NASDAQ: ACONAclarion Inc Stock Ownership - Who owns Aclarion?
Insider buying vs selling
Have Aclarion Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Scott Breidbart | Director | 2026-05-12 | 5,664 | $3.18 | $18.01kBuy |
| David K. Neal | Director | 2026-05-11 | 2,500 | $3.10 | $7.75kBuy |
| Brent Ness | Chief Executive Officer | 2026-05-11 | 6,289 | $3.18 | $20.00kBuy |
| William Wesemann | Director | 2026-05-06 | 1,562 | $3.30 | $5.15kBuy |
| Brent Ness | Chief Executive Officer | 2025-11-26 | 10 | $6.20 | $62.00Buy |
ACON insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ACON insiders and whales buy or sell their stock.
ACON Shareholders
What type of owners hold Aclarion Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Nuvasive Inc | 49.36% | 1,126,495 | $3.49M | Insider |
| John Paul Lorbiecki | 0.98% | 22,404 | $69.45k | Insider |
| Ryan Bond | 0.88% | 20,000 | $62.00k | Insider |
| Captrust Financial Advisors | 0.44% | 10,000 | $31.00k | Institution |
| Brent Ness | 0.28% | 6,300 | $19.53k | Insider |
| Scott Breidbart | 0.25% | 5,664 | $17.56k | Insider |
| Dauntless Investment Group LLC | 0.24% | 5,422 | $16.81k | Institution |
| David K. Neal | 0.11% | 2,502 | $7.76k | Insider |
| William Wesemann | 0.07% | 1,563 | $4.85k | Insider |
| Ubs Group Ag | 0.05% | 1,050 | $3.26k | Institution |
ACON vs Health Information Service Stocks
Aclarion Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.